Stock detail

Cormedix (CRMD) stock price, chart, and key data

View Cormedix stock price, chart movement, and headline metrics on Woodstock's stock detail page.

CRMD

Stock detail

Cormedix

CRMD · XNAS

+$0.82 (+10.31%) past month

$8.77

Pre-market $8.71 (-0.68%)

XNASMarket closedLast updated: Jun 11, 09:31 PM

Key metrics

Earnings

Past Income Statement

128.6M102.9M77.2M51.4M25.7M0
2025 Q2Q42026 Q1
RevenueNet income

Close price

$8.77

Market cap

$688M

52-week range

$6.13 - $17.43

P/E ratio

20.4

About the company

Cormedix Inc

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

QR Code

Contact via LINE

Scan the QR code to get started

LINE QR Code